VaxTrials | Emmes Group

VaxTrials

VaxTrials is Emmes CRO’s vaccine and infectious disease center of excellence. We have been developing and conducting VID interventional and non-interventional studies for over 35 years. With a track record of 650+ clinical trials managed and 350+ journals co-authored, our work has contributed to a number of important vaccines being licensed.

Our therapeutic expertise spans a wide range of conditions. For the past four decades, our infectious disease team has contributed to studies on nearly every major health crisis, including HIV, H1N1, Zika, SARS, MERS, and COVID-19.

Vaccine and Infectious Diseases Leaders

Jose Jimeno

Vaccines and Infectious
Diseases, SVP

Jose Noguera

Business Strategy,
Vaccines and Infectious
Diseases, AVP

Luz Moreno

Medical and
non-interventional studies,
Senior Director

Vivian Gomez

Regional Delivery Expert,
Director

Our Experience, Your Advantage

Global
Footprint with
Local Staff

End-to-End
Use of
Technology
and AI

Fast
Start-Up
Times

High
Recruitment
and Retention
Rates

Solid
Network of
Investigators

Our Operational Model

With the contribution of our local staff, empowered with solid knowledge and understanding of the local context, our approach guarantees seamless project delivery, robust processes, and participant-centered planning, ultimately enhancing trial outcomes and encouraging participant adherence.

Project Management

Seamless end-to-end oversight, following a structured and systematic approach, to ensure integrated and efficient project delivery.

Quality Framework

Enhanced trials through analytic and risk-based solutions, while ensuring robust processes and well-trained resources.

Recruitment and Adherence

Participant-centered approach with data driven planning and decision making, encouraging participant adherence.

Tech and AI Enabled

Utilizing AI to transform trial protocols into structured elements for automated eCRF creation, as well as enhancing efficiency and accuracy in trial management.

Fast Start-Up

High Quality Standards

Efficient Recruitment

High Adherence

Fast Database Lock

Our Achievements

Being enabled by Emmes Group’s technology and AI capabilities allow us to adopt a quick and agile approach, combined with local knowledge, our operational model, our innovative solutions and flexible mindset, we deliver fast startup, efficient recruitment, high adherence, high-quality standards and fast database lock. All crucial factors for the success of VID trials.